Wednesday, January 14, 2009
Elan Considers Sale to Raise Funds for Drug Tests
Elan Considers Sale to Raise Funds for Drug Tests: "Elan Corp., the Irish drugmaker whose shares slumped 72 percent last year, may consider a sale as it seeks funds to test experimental medicines and repay debt.
Citigroup Global Markets Inc. will help review options including a merger, sale or strategic alliance, the Dublin- based company said in a statement. Elan’s shares gained as much as 18 percent today, giving the company a market value of about 3 billion euros ( billion)."
Citigroup Global Markets Inc. will help review options including a merger, sale or strategic alliance, the Dublin- based company said in a statement. Elan’s shares gained as much as 18 percent today, giving the company a market value of about 3 billion euros ( billion)."
